# Determine the Effect of Multiple Doses of AZD7325, CYP Study

> **NCT00790114** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 24 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** AZD7325
- **DRUG:** Midazolam
- **DRUG:** Caffeine

## Key facts

- **NCT ID:** NCT00790114
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2008-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00790114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00790114, "Determine the Effect of Multiple Doses of AZD7325, CYP Study". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00790114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*